RHC – UBS rates the stock as Neutral

APRA data has revealed benefits paid to private hospitals declined -3.3% in the December quarter.

There was reasonably robust growth in Western Australia but NSW was surprisingly weak, UBS notes, with no evidence of significant reductions in any backlog.

The broker retains a Neutral rating and $69.90 target.

Sector: Health Care Equipment & Services.


Target price is $69.90.Current Price is $63.26. Difference: $6.64 – (brackets indicate current price is over target). If RHC meets the UBS target it will return approximately 9% (excluding dividends, fees and charges – negative figures indicate an expected loss).



About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →